Former Chief Scientific Officer, Neuromuscular (8) · Solid Biosciences Inc. (SLDB)

Carl Morris

A named executive officer of Solid Biosciences in every fiscal year CompBrief holds from FY2018 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,559,449

Salary $233,188Stock awards $346,903Bonus $66,107

FY2022: $873,723

1st of 4 named executive officers at Solid Biosciences by FY2023 total.

4 named officers on file for Solid Biosciences, FY2023

Carl Morris’s pay file — $29

  • 4 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Solid Biosciences’s whole pay program stands against its peers

  • Solid Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SLDB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2024 (DEF 14A).

Free

Get Carl Morris’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Carl Morris compensation by year

Solid Biosciences Summary Compensation Table · all 4 fiscal years held
In US dollars, as Solid Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2020FY2022FY2023
Salary$320,000$391,000$430,500$233,188
Bonus$128,000$156,400$66,106$66,107
Stock awards$0$542,560$83,620$346,903
Option awards$3,604,209$134,176$288,154$519,798
Non-equity incentive$0$0$0$0
Pension and deferred compensation$0$0$0$0
All other$0$0$5,343$393,453
Total$4,052,209$1,224,136$873,723$1,559,449

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Solid Biosciences Inc. DEF 14A filed April 26, 2024, accession 0001193125-24-118079, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Solid Biosciences Inc. filed document, accession 0001193125-24-118079. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2024.

$4.1M
$1.2M
$874K
$1.6M
FY18
FY20
FY22
FY23
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU47,555$291,988—
RSU3,700$22,718—
Option95,110—$5.62
Option7,400—$16.95
Option784—$52.05
Option5,834—$102.00
Option13,156—$8.25

Per the Outstanding Equity Awards at Fiscal Year-End table in Solid Biosciences Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Solid Biosciences’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Carl Morris · this pageFormer Chief Scientific Officer, Neuromuscular (8)$1,559,449
Kevin TanChief Financial Officer$1,346,305
Alexander CumboPresident and Chief Executive Officer$918,630
David Tyronne HowtonChief Operating Officer, General Counsel and Secretary$648,880

The full Solid Biosciences compensation record

free company brief

This page is one person within Solid Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Solid Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Carl Morris's compensation dossier · One-time report. No refunds.